Bay Harbor Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Bay Harbor Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$478.3 - $607.98 $30,132 - $38,302	-63 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$544.75 - $658.21 $5,447 - $6,582	10 Added 18.87%	63 $35,000
Q2 2020 Jul 16, 2020	SELL	$493.32 - $643.92 $13,319 - $17,385	-27 Reduced 33.75%	53 $33,000
Q1 2020 May 20, 2020	BUY	$336.18 - $494.43 $22,524 - $33,126	67 Added 515.38%	80 $39,000
Q4 2019 Jan 27, 2020	BUY	$274.13 - $376.51 $1,918 - $2,635	7 Added 116.67%	13 $5,000
Q1 2019 Apr 22, 2019	BUY	$372.08 - $439.57 $2,232 - $2,637	6 New	6 $2,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Bay Harbor Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bay Harbor Wealth Management, LLC with notifications on news.